Sun Altbach
Director/Board Member at Termeer Foundation
Profile
Sun Altbach is a Senior Scientific Advisor at Longevity Vision Fund and an Advisory Board Member at Termeer Foundation.
Previously, she was the President, Chief Executive Officer & Director at PIC Therapeutics, Inc., Senior Director at OvaScience, Inc., and Vice President at Finch Research & Development LLC.
Ms. Altbach received her undergraduate degree from Smith College and her MBA from MIT Sloan School of Management.
Sun Altbach active positions
| Companies | Position | Start |
|---|---|---|
Longevity Vision Fund
 Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Consultant / Advisor | 2021-09-30 |
| Termeer Foundation | Director/Board Member | 2019-12-31 |
Former positions of Sun Altbach
| Companies | Position | End |
|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Chief Executive Officer | 2019-12-31 |
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Private Equity Investor | 2017-12-31 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director/Board Member | 2016-12-31 |
Training of Sun Altbach
| MIT Sloan School of Management | Masters Business Admin |
| Smith College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Longevity Vision Fund
Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Finance |
| Termeer Foundation | |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sun Altbach
